Exact Mass: 380.1430884
Exact Mass Matches: 380.1430884
Found 280 metabolites which its exact mass value is equals to given mass value 380.1430884
,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
Gibberellin A86
Gibberellin A86 (GA86) belongs to the class of organic compounds known as C19-gibberellin 6-carboxylic acids. These are C19-gibberellins with a carboxyl group at the 6-position. Gibberellin A86 is found in fruits. Gibberellin A86 is a constituent of Prunus persica (peaches). Constituent of Prunus persica (peaches). Gibberellin A86 is found in many foods, some of which are peach, sweet cherry, sour cherry, and fruits.
Methyl helianthenoate A glucoside
Methyl helianthenoate A glucoside is found in root vegetables. Methyl helianthenoate A glucoside is a constituent of Helianthus tuberosus (Jerusalem artichoke). Constituent of Helianthus tuberosus (Jerusalem artichoke). Methyl helianthenoate A glucoside is found in root vegetables.
8-Oxodiacetoxyscirpenol
8-Oxodiacetoxyscirpenol is from Fusarium sporotrichioides. From Fusarium sporotrichioides
(S)-Bitalin A 12-glucoside
(S)-Bitalin A 12-glucoside is found in herbs and spices. (S)-Bitalin A 12-glucoside is a constituent of Helichrysum italicum (curry plant). Constituent of Helichrysum italicum (curry plant). (S)-Bitalin A 12-glucoside is found in tea and herbs and spices.
Gibberellin A75
Gibberellin A75 (GA75) belongs to the class of organic compounds known as C19-gibberellin 6-carboxylic acids. These are C19-gibberellins with a carboxyl group at the 6-position. Gibberellin A75 is found in fats and oils. Gibberellin A75 is a constituent of seeds of Helianthus annuus (sunflower). Constituent of seeds of Helianthus annuus (sunflower). Gibberellin A75 is found in sunflower and fats and oils.
N-(5-(((5-(1,1-Dimethylethyl)-2-oxazolyl)methyl)thio)-2-thiazolyl)-4-piperidinecarboxamide
C17H24N4O2S2 (380.13406039999995)
C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C2185 - Cyclin-Dependent Kinase Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent
Amosulalol
C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C72900 - Adrenergic Antagonist D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D018674 - Adrenergic Antagonists D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents
Egtazic acid
D064449 - Sequestering Agents > D002614 - Chelating Agents > D065096 - Calcium Chelating Agents D020011 - Protective Agents > D000931 - Antidotes
Varespladib
C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS Varespladib (LY315920) is a potent and selective group IIA, secretory phospholipase A2 (sPLA2) inhibitor with an IC50 of 9 nM. Varespladib exhibits the significant inhibitory effect on sPLA2 activity in serum from various species including rat, rabbit, guinea pig and human with IC50s of 8.1 nM, 5.0 nM, 3.2 nM and 6.2 nM, respectively[1].
[3aR-(3aR*,4S*,5R*,6E,10S*,11R*,11aS*)]-2,3,3a,4,5,8,9,10,11,11a-Decahydro-5,10,11-trihydroxy-6,10-dimethyl-3-methylene-2,9-dioxocyclodeca[b]furan-4-yl ester 2-methyl-2-propenoic acid
3,15-Diacetyldeoxynivalenol
D009676 - Noxae > D011042 - Poisons > D014255 - Trichothecenes D009676 - Noxae > D011042 - Poisons > D009183 - Mycotoxins CONFIDENCE isolated standard
1,2-O-Ethylidene,4,6-di-Ac,3-benzyl-alpha-D-Pyranose-Allose
3beta,13-diacetoxy-1alpha-hydroperoxygermacra-4E,9Z,7(11)-triene-12,6alpha-olide
6-acetyl-2,2-dimethylchromene-8-O-beta-D-glucopyranoside
8alpha-acetoxy-4alpha,5alpha-epoxyjalcaguaianolide 13-O-acetate
[3aR-(3aR*,4S*,5R*,6E,10S*,11R*,11aS*)]-2,3,3a,4,5,8,9,10,11,11a-Decahydro-5,10,11-trihydroxy-6,10-dimethyl-3-methylene-2,9-dioxocyclodeca[b]furan-4-yl ester 2-methyl-2-propenoic acid
2-Methyl-3-(hydroxymethyl)-3,4-dihydro-4-[[2-(3,4-dihydroxyphenyl)ethyloxy]carbonylmethyl]-2H-pyran-5-carboxylic acid methyl ester
(1R,6S,7R,8S,10R)-8,14-diacetoxy-1(10)-epoxy-15-hydroxygermacra-1(10),4,11(13)-trien-6,12-olide
(2E,8E,10E,12R)-tridecatriene-4,6-diyne-1,12,13-triol-1-O-beta-D-glucopyranoside
butyl 7-{(benzoyloxy)methyl}-3,8-dihydroxy-2,6-dioxabicyclo[3.2.1]octane-3-carboxylate|decurrenside E
5,6-Dihydro-hypothemycin|5,6-dihydrohypothemycin|7,8-dihydrohypothemycin|dihydrohypothemycin
3beta,9beta-diacetoxy-1beta-hydroperoxy-6beta,7alphaH-germacra-4,10(14),11(13)-trien-12,6alpha-olide
3beta,13-diacetoxy-1beta-hydroxygermacra-4E,7(11),10(14)-triene-12,6alpha-olide
1,2-bis(4-hydroxy-3,5-dimethoxyphenyl)propane-1,3-diol
(1S*,2R*,5R*,6R*,7S*,8R*,9R*10S*)-2,9-diacetoxy-8,10-dihydroxyguaia-3,11(13)-diene-6,12-olide
1??,3??,15-Trihydroxy-3,10-epoxy-8??-O-methacryloyl-4,11-germacradiene,6??,12-olide
MLS001401364-01!Cilastatin sodium
C16H25N2NaO5S (380.13818000000003)
methyl 4-(4,6-dihydroxy-5-methoxy-2,5-dimethyl-3-oxocyclohexen-1-yl)oxy-2-hydroxy-3,6-dimethylbenzoate
methyl 2-(4,5-dihydroxy-6-methoxy-3,6-dimethyl-2-oxocyclohex-3-en-1-yl)oxy-4-hydroxy-3,6-dimethylbenzoate
methyl 2-(4,5-dihydroxy-6-methoxy-3,6-dimethyl-2-oxocyclohex-3-en-1-yl)oxy-4-hydroxy-3,6-dimethylbenzoate
methyl 4-(4,6-dihydroxy-5-methoxy-2,5-dimethyl-3-oxocyclohexen-1-yl)oxy-2-hydroxy-3,6-dimethylbenzoate
methyl 2-(4,5-dihydroxy-6-methoxy-3,6-dimethyl-2-oxocyclohex-3-en-1-yl)oxy-4-hydroxy-3,6-dimethylbenzoate [IIN-based on: CCMSLIB00000848087]
methyl 2-(4,5-dihydroxy-6-methoxy-3,6-dimethyl-2-oxocyclohex-3-en-1-yl)oxy-4-hydroxy-3,6-dimethylbenzoate [IIN-based: Match]
Ala Cys Ser Thr
Ala Cys Thr Ser
Ala Ser Cys Thr
Ala Ser Thr Cys
Ala Thr Cys Ser
Ala Thr Ser Cys
Cys Ala Ser Thr
Cys Ala Thr Ser
Cys Gly Thr Thr
Cys Ser Ala Thr
Cys Ser Thr Ala
Cys Thr Ala Ser
Cys Thr Gly Thr
Cys Thr Ser Ala
Cys Thr Thr Gly
Gly Cys Thr Thr
Gly Met Ser Ser
Gly Ser Met Ser
Gly Ser Ser Met
Gly Thr Cys Thr
Gly Thr Thr Cys
Met Gly Ser Ser
Met Ser Gly Ser
Met Ser Ser Gly
Ser Ala Cys Thr
Ser Ala Thr Cys
Ser Cys Ala Thr
Ser Cys Thr Ala
Ser Gly Met Ser
Ser Gly Ser Met
Ser Met Gly Ser
Ser Met Ser Gly
Ser Ser Gly Met
Ser Ser Met Gly
Ser Thr Ala Cys
Ser Thr Cys Ala
Thr Ala Cys Ser
Thr Ala Ser Cys
Thr Cys Ala Ser
Thr Cys Gly Thr
Thr Cys Ser Ala
Thr Cys Thr Gly
Thr Gly Cys Thr
Thr Gly Thr Cys
Thr Ser Ala Cys
Thr Ser Cys Ala
Thr Thr Cys Gly
Thr Thr Gly Cys
Gibberellin A75
8-Oxodiacetoxyscirpenol
(S)-Bitalin A 12-glucoside
Gibberellin A86
Methyl helianthenoate A glucoside
Methyl 2-[(4,5-dihydroxy-6-methoxy-3,6-dimethyl-2-oxo-3-cyclohexen-1-yl)oxy]-4-hydroxy-3,6-dimethylbenzoate
2-aminophthalylhydrazido-n-acetyl-b-d-glucosaminide
(4-(TRIPHENYLSILYL)PHENYL)BORONIC ACID
C24H21BO2Si (380.14037959999996)
N-tert-butyl-N-[2-[(5-chloro-1,3-benzoxazol-2-yl)-(3-oxobutyl)amino]ethyl]carbamate
C18H23ClN3O4 (380.13770080000006)
1-(2-AMINO-PHENYL)-PIPERIDINE-3-CARBOXYLICACIDETHYLESTER
C20H20N4O4 (380.14844800000003)
XRP44X
XRP44X inhibits Ras-induced transcription activation with the IC50 of 10 nM. XRP44X inhibits activation of the Ras-Erk-1/2 pathway by FGF-2[1]. XRP44X is an inhibitor of Ras/Erk activation of Elk3 that also affects microtubules[2].
1-(2,4,6-TRIISOPROPYLBENZENESULFONYL)-3-NITRO-1H-1,2,4-TRIAZOLE
trabodenoson
C78283 - Agent Affecting Organs of Special Senses > C29705 - Anti-glaucoma Agent C78274 - Agent Affecting Cardiovascular System > C29707 - Vasodilating Agent Trabodenoson (INO-8875), an adenosine mimetic, is a highly selective Adenosine A1 receptor agonist. Trabodenoson (INO-8875) is used in the study for Primary Open-Angle Glaucoma[1].
3(S)-BOC-AMINO-2,3-DIHYDRO-4-OXO-1,5-BENZOTHIAZEPINE-5(2H)-ACETIC ACID ETHYL ESTER
(1R,2R,N1E,N2E)-N1,N2-bis(2-nitrobenzylidene)cyclohexane-1,2-diamine
C20H20N4O4 (380.14844800000003)
diethyl 3,6-diphenyl-1,2,4,5-tetrazine-1,2-dicarboxylate
C20H20N4O4 (380.14844800000003)
3-(1H-2-INDOLYL)-4-(4-METHOXYPHENYL)-1-METHYL-1H-2-QUINOLINONE
4-(3-{[5-(Trifluoromethyl)pyridin-2-Yl]oxy}benzyl)piperidine-1-Carboxylic Acid
Egtazic acid
D064449 - Sequestering Agents > D002614 - Chelating Agents > D065096 - Calcium Chelating Agents D020011 - Protective Agents > D000931 - Antidotes
Cilastatin Sodium
C16H25N2NaO5S (380.13818000000003)
D004791 - Enzyme Inhibitors > D011480 - Protease Inhibitors C471 - Enzyme Inhibitor > C783 - Protease Inhibitor
Varespladib
C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS Varespladib (LY315920) is a potent and selective group IIA, secretory phospholipase A2 (sPLA2) inhibitor with an IC50 of 9 nM. Varespladib exhibits the significant inhibitory effect on sPLA2 activity in serum from various species including rat, rabbit, guinea pig and human with IC50s of 8.1 nM, 5.0 nM, 3.2 nM and 6.2 nM, respectively[1].
Amosulalol
C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C72900 - Adrenergic Antagonist D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D018674 - Adrenergic Antagonists D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents
4,5,7,12-Tetrahydroxy-11-methyl-6-methylidene-16-oxo-15-oxapentacyclo[9.3.2.15,8.01,10.02,8]heptadecane-9-carboxylic acid
5,7,12,13-Tetrahydroxy-11-methyl-6-methylidene-16-oxo-15-oxapentacyclo[9.3.2.15,8.01,10.02,8]heptadecane-9-carboxylic acid
4,6-bis(1-imidazolyl)-N,N-diphenyl-1,3,5-triazin-2-amine
N-(3,4-dimethoxyphenyl)-7-methoxy-4,5-dihydrobenzo[g][1,2]benzoxazole-3-carboxamide
2-(4-Anilinophenoxy)acetic acid [2-(2-furanylmethylamino)-2-oxoethyl] ester
N-(3-methoxyphenyl)-1,3-dioxo-2-(2-oxolanylmethyl)-5-isoindolecarboxamide
Cyclopropanecarboxylic acid [5-(6-amino-5-cyano-3-methyl-2,4-dihydropyrano[2,3-c]pyrazol-4-yl)-2-ethoxyphenyl] ester
C20H20N4O4 (380.14844800000003)
(3aR,6aS)-3-(3,4-dimethoxyphenyl)-5-(2,4-dimethylphenyl)-3a,6a-dihydropyrrolo[3,4-d]isoxazole-4,6-dione
N-(1,3-benzodioxol-5-yl)-2-[ethyl-[(4-oxo-1H-quinazolin-2-yl)methyl]amino]acetamide
C20H20N4O4 (380.14844800000003)
methyl 2-[4-ethyl-2-methoxy-5-oxo-2-(9H-pyrido[3,4-b]indol-1-yl)furan-3-yl]acetate
Methyl (9R,12R,21S)-15,20-dioxo-19-oxa-8,16-diazahexacyclo[10.6.4.01,9.02,7.09,21.012,16]docosa-2,4,6,13-tetraene-8-carboxylate
1-(3,4-dimethylphenyl)-6-hydroxy-5-[(Z)-[(4-methoxyphenyl)hydrazinylidene]methyl]pyrimidine-2,4-dione
C20H20N4O4 (380.14844800000003)
2-(4-(4-Nitrophenyl)butan-2-ylamino)-1-(4-methoxyphenyl)ethanol Hydrochloride
1-(4-Chlorophenyl)-2-[4-methyl-6-(2-phenylethylamino)pyrimidin-2-yl]guanidine
(3S)-5-Bromo-3-(tert-butyldimethylsilyloxy)-1-pivaloyloxypentane
C16H33BrO3Si (380.13822079999994)
SNS-032 (BMS-387032)
C17H24N4O2S2 (380.13406039999995)
C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C2185 - Cyclin-Dependent Kinase Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent